newsfilter
← Latest News
GlobeNewswire·

Histogen Announces Initiation of HST 003 Phase 1/2 Trial for Knee Cartilage Regeneration

SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:HSTO), today announced the initiation of its Phase 1/2 clinical trial of HST 003 to evaluate the safety and efficacy of human extracellular matrix (hECM:HST 003) implanted within microf